Top Story

AACR presents research award

October 1, 2014

Graham A. Colditz, MD, DrPH, received the American Association for Cancer Research’s 2014 AACR Award for Outstanding Achievement in Cancer Prevention Research.

Colditz — associate director of prevention and control, professor of surgery and professor of medicine at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis — received the award at the 13th annual AACR International Conference on Frontiers in Cancer Prevention Research.

Just-in-Time management principles helped reduce patient wait time

October 1, 2014
Applying processes used in manufacturing to streamline patient flow can successfully reduce patient wait time and increase the confidence of residents at teaching…
figure In the Journals

Less disease education linked to greater decisional conflict in prostate cancer

October 1, 2014
Patients with less knowledge about prostate cancer are more likely to have decisional conflict and have less confidence in their decision-making effectiveness, according…
FDA News

FDA grants aldoxorubicin orphan drug status

October 1, 2014
CytRx Corp. announced that the FDA granted multiple orphan drug designation to aldoxorubicin for the treatment of patients with glioblastoma multiforme, small cell lung…
More News Headlines »

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »